
FEATURED CONTENT
-
Discover the pros and cons of telehealth visits and what can be done to continuously improve them.
-
Gain insight into why the call center must be viewed as an integral component of the clinical trial experience.
-
Discover the important role of clinician reported outcomes (ClinROs) when it comes to regulatory submissions.
-
In this blog, Joan Venticinque tells us about her health journey when she discovered she was positive for COVID-19.
-
Learn how drug makers worldwide need to ensure that conditions for bias are not created as a result of access to devices or WiFi when it comes to clinical research.
-
The US has already achieved its target of 100 million Americans vaccinated in 100 days. Despite this huge milestone, discover how the registration for the vaccine itself has been anything but simple.
-
Learn why you don't need to take an all-or-nothing approach when it comes to decentralized trials.
-
At the beginning of the pandemic, thousands of clinical trials were suspended for the safety of investigators and participants alike. Once the FDA issued guidance for conducting trials virtually, discover the ways the industry embraced them and their benefits.
-
Find out how digital biomarkers stand to have a profound impact on, and even enable, the digital transformation of the healthcare industry and DCTs.
-
Learn how decentralized clinical trials featuring technology-enabled communications are empowering researchers to create a more patient-centric clinical trial and transforming the clinical trial experience for patients.
-
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
-
Explore how consent is a critical step that can greatly influence patient enrollment, adherence and retention in the trial.
-
As the Senior Director and Co-Owner of Coastal Carolina Research Center, Nathan Morton provides strategic planning and operational oversight for a dedicated research center and clinical staff of 50. In this conversation, learn about his thoughts on the decentralized trial landscape.
-
In this article, learn more about COAs, and their electronic counterparts, eCOAs.
-
Learn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.
-
Read on to learn why patient reported outcomes (PROs) are essential, how they can be captured electronically, and how they impact clinical trial participants.
-
Clinical trials are essential for the development of new medical treatments and devices. However, enrolling patients in clinical trials is one of the most challenging aspects of conducting these studies.
-
Read to learn more about ClinROs, why they are important, the industry governance around them, and how their electronic versions can benefit clinical trials.
-
Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.
-
Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns.
ABOUT MEDABLE
Medable’s mission is to get effective therapies to patients faster while expanding clinical research to every body, eliminating critical barriers to access such as income status, geography, & race. Medable offers a proven decentralized clinical trial platform that shortens trial timelines, creates operational efficiencies, and expands trial access to anyone worldwide using a combination of screening, eConsent, eCOA, ePRO, real-world data, connected sensors & more.
Founded by visionary CEO Dr. Michelle Longmire after discovering firsthand the difficulties of finding research patients, Medable’s platform is designed by a combination of clinicians, patients, and tech experts to ease the experience for all trial stakeholders. The result is over 150+ decentralized trials conducted across 60+ countries with over 1 million patients accessing our platform today.
A pioneer in patient-centric trials, Medable has been ranked the number one provider of decentralized clinical trials by the Everest Group, and recently collaborated with Tufts CSDD to release the first financial modeling showcasing the benefits of DCTs. Medable DCTs have now demonstrated net financial benefits of up to 5x & 14x greater than the initial upfront investment required for phase ll & phase lll studies, respectively. Additionally, our digital certification program has helped teach decentralized and patient-centric clinical trial methods to over 1,000+ of our industry peers.
Find out how Medable can partner with your organization to digitally transform your clinical protocols. Your research teams can experience benefits such as; improved patient experience, higher quality outcomes data, & savings of US$25,000,000+ for individual studies. Please visit www.Medable.com for further information.
CONTACT INFORMATION
Medable
525 University Ave, Suite A70
Palo Alto, CA 94301
UNITED STATES
WEBINARS
-
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
-
In this webinar, Medable SMEs take you through the end-to-end process of conducting decentralized clinical research, including benefits, common pitfalls and challenges, and more.
-
In this webinar, industry experts share their perspectives on how to address drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
-
In this webinar, learn how to develop a unified platform experience, deploy flexible solutions to enable diverse patient-invested clinical trials, and contextualize data to make actionable data points for practitioners' workflows.
-
In this free webinar, learn how to update your clinical data strategy that ensures you can scale trials globally while decreasing the overall burden on sites and patients.
-
In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.
-
What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.
-
Find out why bringing the on-site experience into patients' homes can make clinical research, and therefore treatments, work for everybody.